Herein, we have investigated the distribution of all somatic histone H1 variants present in breast cancer cells, i.e. H1.0, H1X and H1.2 to H1.5 by combining ChIP with genomic technologies such as tiling promoter array hybridization and high-resolution sequencing. Here, H1-0 is linked to breast cancer.